Endoskopisches System zur Therapie bei Typ-2-Diabetes und Adipositas – Duodenal-Jejunal Bypass Liner

• Literatur

• 1 Escalona A et al. Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year with an Endoscopic Duodenal-Jejunal Bypass Liner. Annals of Surgery 2012; 255 (Suppl. 06) 1080-5
• 2 de Jonge C et al. Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes. Obesity Surgery 2013; 23 (Suppl. 09) 1354-60
• 3 Muñoz R et al. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Surgical Endoscopy 07.11.2013;
• 4 de Moura EGH et al. Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal-Jejunal Bypass Liner. Diabetes Technology & Therapeutics 2012; 14 (Suppl. 02) 1-7
• 5 Cohen RV et al. Pathophysiology Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes. Diabetic Medicine 26.06.2013;
• 6 De Jonge C et al. Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Plasma Parameters of Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2013; 11 (Suppl. 11) 1517-20
• 7 Hickey MS et al. A New Paradigm for Type 2 Diabetes Mellitus Could It Be a Disease of the Foregut?. Annals of Surgery 1998; 227 (Suppl. 05) 637-44
• 8 Gass M, Beglinger C, Peterli R. Metabolic Surgery – principles and current concepts- Langenbeck’s. Archives of Surgery 2011; 396: 949-72
• 9 de Jonge C et al. The impact of the EndoBarrier on body weight and satiety hormones. Poster presentation 20^th United European Gastroenterology Week (UEGW), 2012
• 10 Brubaker PL. Minireview: Update on incretin biology: focus on glucagon-like peptide-1. Endocrinology 2010; 151 (Suppl. 05) 1984-9